Lack of association of a variable number of aspartic acid residues in the asporin gene with osteoarthritis susceptibility: case-control studies in Spanish Caucasians.
A recent genetic association study has identified a microsatellite in the coding sequence of the asporin gene as a susceptibility factor for osteoarthritis (OA). Alleles of this microsatellite determine the variable number of aspartic acid residues in the amino-terminal end of the asporin protein. Asporin binds directly to the growth factor transforming growth factor beta and inhibits its anabolic effects in cartilage, which include stimulation of collagen and aggrecan synthesis. The OA-associated allele, with 14 aspartic acid residues, inhibits the anabolic effects of transforming growth factor beta more strongly than other asporin alleles, leading to increased OA liability. We have explored whether the association found in several cohorts of Japanese hip OA and knee OA patients was also present in Spanish Caucasians. We studied patients that had undergone total joint replacement for primary OA in the hip (n = 303) or the knee (n = 188) and patients with hand OA (n = 233), and we compared their results with controls (n = 294) lacking overt OA clinical symptoms. No significant differences were observed in any of the multiple comparisons performed, which included global tests of allele frequency distributions and specific comparisons as well as stratification by affected joint and by sex. Our results, together with reports from the United Kingdom and Greece, indicate that the stretch of aspartic acid residues in asporin is not an important factor in OA susceptibility among European Caucasians. It remains possible that lifestyle, environmental or genetic differences allow for an important effect of asporin variants in other ethnic groups as has been reported in the Japanese, but this should be supported by additional studies.
Laboratorio de Investigacion 2 and Rheumatology Unit, Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain.
Julio
J
Rodriguez-Lopez
Manuel
M
Pombo-Suarez
Myriam
M
Liz
Juan J
JJ
Gomez-Reino
Antonio
A
Gonzalez
D019644:Arthroplasty, Replacement, Hip; D001224:Aspartic Acid / Q000032:analysis*; D001483:Base Sequence; D002352:Carrier Proteins / Q000737:chemistry / Q000235:genetics*; D016022:Case-Control Studies; D016001:Confidence Intervals; D004247:DNA / Q000097:blood / Q000235:genetics; D017931:DNA Primers; D016326:Extracellular Matrix Proteins; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D006801:Humans; D007564:Japan; D008297:Male; D018895:Microsatellite Repeats; D010003:Osteoarthritis / Q000097:blood / Q000235:genetics* / Q000601:surgery; D016133:Polymerase Chain Reaction; D012016:Reference Values; D013030:Spain; D044465:White People
C439889:ASPN protein, human; D002352:Carrier Proteins; D017931:DNA Primers; D016326:Extracellular Matrix Proteins; D001224:Aspartic Acid; D004247:DNA